| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |